Amanote Research
Register
Sign In
RIG-I Inhibits SRC-Mediated AKT/mTOR Signaling and Stemness in AML
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2014-015
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
January 23, 2014
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
RIG-I Modulates SRC-Mediated AKT Activation to Restrain Leukemic Stemness
Molecular Cell
Cell Biology
Molecular Biology
Hepatitis B Virus Inhibits Intrinsic RIG-I and RIG-G Immune Signaling via Inducing miR146a
Scientific Reports
Multidisciplinary
Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway
Chinese Medicine
Wedelolactone Inhibits Breast Cancer-Induced Osteoclastogenesis by Decreasing Akt/mTOR Signaling
International Journal of Oncology
Cancer Research
Oncology
Hesperidin Inhibits Vascular Formation by Blocking the AKT/mTOR Signaling Pathways
Preventive Nutrition and Food Science
Nutrition
Food Science
Dietetics
24-Methylenecycloartanyl Ferulate Induces PPAR-γ2 Mediated Regulation of Angiogenesis-Related Genes and Inhibits Akt/mTOR Signaling
USP3 Inhibits Type I Interferon Signaling by Deubiquitinating RIG-I-like Receptors
Cell Research
Cell Biology
Molecular Biology
Overexpression of RASD1 Inhibits Glioma Cell Migration/Invasion and Inactivates the AKT/mTOR Signaling Pathway
Scientific Reports
Multidisciplinary
Ibrutinib Inhibits SDF1/CXCR4 Mediated Migration in AML
Oncotarget
Oncology
